Posts

Psychedelic Stocks Compass Small Pharma Mydecine Awakn

A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial

,
Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research
Compass Pathways Appoints a New CEO

Compass Pathways Appoints a New CEO

,
George Goldsmith will be replaced as Compass Pathways CEO. Is this good or bad news?